Viewing Study NCT01662050


Ignite Creation Date: 2025-12-24 @ 5:20 PM
Ignite Modification Date: 2025-12-31 @ 1:31 AM
Study NCT ID: NCT01662050
Status: COMPLETED
Last Update Posted: 2022-08-09
First Post: 2012-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Age-Adjusted Rituximab, Bendamustine, Cytarabine as Induction Therapy in Older Patients With MCL
Sponsor: Fondazione Italiana Linfomi - ETS
Organization: